Cara Therapeutics (CARA) Operating Income US GAAP (year values)

2020 2021 2022 2023 2023   LTM ? CAGR 5 years ?
Operating Income, bln rub 5.39 -89.1 -87.5 -121.5 -121.5   -108.7  
Changes by years, y/y, % -105% -1 754% -2% +39% 0%     +9.4%

Cara Therapeutics. Operating Income, bln rub

Cara Therapeutics. Operating Income, changes, %

Cara Therapeutics. Operating Income, sum by quarters, bln rub

Cara Therapeutics (CARA) Operating Income US GAAP (quarter values)

2023Q3 2023Q4 2023Q4 2024Q1 2024Q2   LTM ?
Operating Income, bln rub -28.0 -32.6 -32.6 -27.3 -16.2   -108.7
Changes by years, y/y, % +18% +4% +4% -1% -50%    
Changes by quarters, q/q, % -13% +16% 0% -16% -41%    

Cara Therapeutics. Operating Income, bln rub

Cara Therapeutics. Operating Income, changes, y/y, %

Cara Therapeutics. Operating Income, changes, q/q, %